Oncological perineal massage in vaginal stenosis and dyspareunia in women with gynecological cancer: a randomized controlled trial
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Background Dyspareunia and vaginal stenosis are common complications in gynecological cancer survivors. Despite the widespread use of passive vaginal dilator therapy, physiotherapy interventions like oncological perineal massage (MPO ® ) have not been thoroughly evaluated. Objective Tis study aims to compare the effectiveness of MPO ® perineal massage versus standard passive vaginal dilator therapy in managing dyspareunia, vaginal stenosis, sexual function, and quality of life in women with gynecological cancer. Methods A randomized controlled trial involving 35 women (MPO ® group: n = 18; control group: n =17) was conducted. The participants underwent either MPO ® massage or passive dilator therapy for 10 weeks, with assessments at baseline (T0), mid-treatment (T1), post-treatment (T2), and 6-month follow-up (T3). Outcomes included pain (VAS), vaginal stenosis (CTCAE 5.0), sexual function (FSM-2), and quality of life (EORTC QLQ-C30). Results The MPO ® group demonstrated significantly greater reductions in vaginal pain (median VAS: 8.5 at T0 to 0 at T3, p <0.001), with improvements also seen in vaginal stenosis (absence/presence at T3: 16/2 vs. 3/14 in controls, p <0.001), sexual function (notably lubrication, penetration ease, and satisfaction), and quality of life (QLQ-C30 median score: 32.5 at T0 to 30 at T3 in MPO ® vs. 35 to 32 in controls, p <0.001). Conclusion Oncological perineal massage (MPO ® ) significantly improved pain, vaginal stenosis, sexual function, and quality of life in gynecological cancer survivors compared to passive dilator therapy. These findings support incorporating manual therapy techniques in comprehensive survivorship care in this population. Clinical Trial Registration ClinicalTrials [ https://clinicaltrials.gov/study/NCT06432998 ], identifier NCT06432998.
Source: Frontiers in Oncology
Institutions: Universidad de Alcalá, Universidad Europea de Madrid
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W4416774145
